Ukko
About
Ukko is dedicated to improving the lives of individuals suffering from food allergies and disorders. They leverage cutting-edge technologies in immunology, computational biology, and plant science to create innovative therapeutic approaches. The company has a presence in Tel Aviv, Israel, and Palo Alto, California.
Key facts
At-a-glance profile data
- Website
- ukko.us
- Headquarters
- Palo Alto, United States
- Founded
- 2016
- Employees
- 58
- Total funding
- $40M (Series B)
- Business model
- B2B
- Tags
- HealthcareAllergenImmunologyCeliacGenomics
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 27 Jan 2021 | Series B | $40M | - |
Tech stack
Detected on ukko.us, last scanned 19 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Ukko raised?
Ukko has raised a total of $40M in funding. The most recent round on record is Series B.
How many employees does Ukko have?
Ukko has approximately 58 people on record.